Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew F Wipperman

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.
Osteoarthritis and Cartilage Open|January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial dataMatthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
Frontiers in Neurology|July 9, 2025
Reliable monitoring of respiratory function with home spirometry in people living with amyotrophic lateral sclerosisJulián Peller, Marcos A Trevisan, Gaston Bujia, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Elife|April 30, 2024
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learningMatthew F Wipperman, Allen Z Lin, Kaitlyn M Gayvert, et al.
The New England Journal of Medicine|December 22, 2022
Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Marc E Rothenberg, Margaret H Collins, et al.
Science Translational Medicine|October 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthmaSeblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.
Osteoarthritis and Cartilage Open|January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial dataMatthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
Frontiers in Neurology|July 9, 2025
Reliable monitoring of respiratory function with home spirometry in people living with amyotrophic lateral sclerosisJulián Peller, Marcos A Trevisan, Gaston Bujia, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Elife|April 30, 2024
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learningMatthew F Wipperman, Allen Z Lin, Kaitlyn M Gayvert, et al.
The New England Journal of Medicine|December 22, 2022
Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Marc E Rothenberg, Margaret H Collins, et al.
Science Translational Medicine|October 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthmaSeblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Pageof 4